Russell Investments Group’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-22
| Closed | -$970 | – | 3586 |
|
|
2024
Q1 | $970 | Buy |
22
+16
| +267% | +$705 | ﹤0.01% | 3136 |
|
|
2023
Q4 | $260 | Buy |
+6
| New | +$260 | ﹤0.01% | 3166 |
|
|
2023
Q2 | – | Sell |
-13
| Closed | -$3.88K | – | 3458 |
|
|
2023
Q1 | $3.88K | Buy |
+13
| New | +$3.88K | ﹤0.01% | 2965 |
|
|
2021
Q3 | – | Sell |
-40
| Closed | -$18K | – | 3055 |
|
|
2021
Q2 | $18K | Sell |
40
-1,212
| -97% | -$545K | ﹤0.01% | 3177 |
|
|
2021
Q1 | $862K | Sell |
1,252
-121
| -9% | -$83.3K | ﹤0.01% | 2307 |
|
|
2020
Q4 | $1.02M | Buy |
1,373
+756
| +123% | +$559K | ﹤0.01% | 2111 |
|
|
2020
Q3 | $426K | Hold |
617
| – | – | ﹤0.01% | 2460 |
|
|
2020
Q2 | $521K | Sell |
617
-609
| -50% | -$514K | ﹤0.01% | 2365 |
|
|
2020
Q1 | $440K | Buy |
+1,226
| New | +$440K | ﹤0.01% | 2231 |
|